Kyverna Therapeutics, Inc.KYTXNASDAQ
LOADING
|||
Operating Income Contraction
Trending lower, below historical average, strong compound growth.
Left:
||||
Profit from core business operations before interest and taxes
Latest
$-142.60M
↓ 119% below average
Average (3y)
$-65.19M
Historical baseline
Range
High:$-26.35M
Low:$-142.60M
CAGR
+75.6%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $-142.60M | -128.5% |
| 2023 | $-62.41M | -112.4% |
| 2022 | $-29.38M | -11.5% |
| 2021 | $-26.35M | - |